# Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis

> **NCT02215993** · PHASE4 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 50 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Platelet Function

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02215993
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02215993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02215993, "Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02215993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*